Get the Stockscreener App
12.18
0.65%
-0.08
Why is Atara Biotherapeutics Inc (ATRA) Stock down?
We've noticed a 5.58% decline in Atara Biotherapeutics Inc (ATRA) stock during the 2024-11-18 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!
09 Nov, 2023:
Atara Biotherapeutics Stock (ATRA) dropped by 80.17% from $1.21 to $0.24 in the trading on Thursday November 9, 2023. The reason why ATRA stock down today is due to primary result of the study. Atara said that a Phase 2 study for its drug ATA188 in the treatment of multiple sclerosis failed to meet its primary endpoint. Atara said it is evaluating the data to decide the next steps for the program, but anticipates stopping the study as no treatment benefit was observed.
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):